Alvaro Cobo Calvo Institutions of which they are part Main researcher Clinical Neuroimmunology Vall Hebron Institut de Recerca Email Alvaro Cobo Calvo Email Institutions of which they are part Main researcher Clinical Neuroimmunology Vall Hebron Institut de Recerca
Projects SGR-Cat 2021: Neuroimmunologia Clínica IP: SGR-Cat 2021: Neuroimmunologia Clínica Collaborators: Carlos Nos Llopis, SGR-Cat 2021: Neuroimmunologia Clínica, José Ant. Graells Salvador, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Andrea Serrano Mascarós, Margarida Capell Maymo, Samuel Sánchez Pous, Elisenda Anglada Clofent, Montserrat Aroca Alsina, Sergio Cabello, Carmen Tur Gomez, Gabriel Ig Camiña Rodríguez, Herena Eixarch Ahufinger, Carme Santoyo Medina, Oriol Nualart Mundo, Mar Tintore Subirana, M Jesus Arevalo Navines, Edwin Roger Meza Murillo, Augusto Cesar Sao Aviles, Miguel Angel Robles Sanchez, Dunia Muñoz Valdivielso, Carmen Espejo Ruiz, Gaizka Loyola Sanmillan, Mireia Resina Salles, Angela Vidal Jordana, Lucía Gutiérrez Ruiz, Ana Zabalza de Torres, Sergio Vergara Ruiz, Rafael Garcia Merida, Luciana Midaglia Fernandez, Alvaro Cobo Calvo, Neus Mongay Ochoa, Joaquin Castillo Justribo, Milagros Fraga Pereira, Breogan Rodriguez Acevedo, Andres Miguez Gonzalez, Mireia Castillo Juarez, Rucsanda Pinteac, Nicolás Miguel Fissolo Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 40000 Reference: 2021 SGR 00782 Duration: 01/01/2022 - 30/06/2025 Deciphering clinical features and pathogenesis of myelin oligodendrocyte glycoprotein (MOG) antibodies in adult patients with a first demyelinating syndrome IP: Alvaro Cobo Calvo Collaborators: Miriam Izquierdo Sans Funding agency: Instituto de Salud Carlos III Funding: 119567 Reference: FI21/00282 Duration: 01/01/2022 - 31/12/2025 Deciphering clinical features and pathogenesis of myelin oligodendrocyte glycoprotein (MOG) antibodies in adult patients with a first demyelinating syndrome IP: Alvaro Cobo Calvo Collaborators: Rosalia Horno Ocaña, Cristina Auger Acosta, Luciana Midaglia Fernandez, Breogan Rodriguez Acevedo, Mireia Castillo Juarez Funding agency: Instituto de Salud Carlos III Funding: 134915 Reference: PI20/00800 Duration: 01/01/2021 - 30/06/2025 Utilidad de biomarcadores de suero y líquido cefalorraquídeo en la evaluación del pronóstico y respuesta a tratamiento en pacientes con fases iniciales de Esclerosis Multiple IP: Manuel Comabella Lopez Collaborators: Alvaro Cobo Calvo, Miriam Izquierdo Sans Funding agency: Instituto de Salud Carlos III Funding: 180000 Reference: JR19/00007 Duration: 01/01/2020 - 31/12/2023 Pagination First page « Previous page ‹ Page 1 Current page 2
